Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion type Assertion NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_head.
- NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion description "[Patients with t(8;21)-AML expressing CD56 have been reported to exhibit a higher incidence of granulocytic sarcoma (GS), and t(8;21)-AML with GS results in a less favorable prognosis than AML with this translocation alone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_provenance.
- NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion evidence source_evidence_literature NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_provenance.
- NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion SIO_000772 21156247 NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_provenance.
- NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion wasDerivedFrom befree-20140225 NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_provenance.
- NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_assertion wasGeneratedBy ECO_0000203 NP198579.RABMQR55G0JFT8it_nlJNmI3b1LLY5tBsNEGbhi1-KUE8130_provenance.